GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huons Co Ltd (XKRX:243070) » Definitions » EBITDA Margin %

Huons Co (XKRX:243070) EBITDA Margin % : 12.62% (As of Mar. 2025)


View and export this data going back to 2006. Start your Free Trial

What is Huons Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Huons Co's EBITDA for the three months ended in Mar. 2025 was ₩18,405 Mil. Huons Co's Revenue for the three months ended in Mar. 2025 was ₩145,836 Mil. Therefore, Huons Co's EBITDA margin for the quarter that ended in Mar. 2025 was 12.62%.


Huons Co EBITDA Margin % Historical Data

The historical data trend for Huons Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huons Co EBITDA Margin % Chart

Huons Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only 20.94 12.91 12.22 15.19 10.54

Huons Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.80 9.66 9.29 12.42 12.62

Competitive Comparison of Huons Co's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Huons Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huons Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huons Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Huons Co's EBITDA Margin % falls into.


;
;

Huons Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Huons Co's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=62200.346/590231.06
=10.54 %

Huons Co's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=18405.456/145835.894
=12.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Huons Co  (XKRX:243070) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Huons Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Huons Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Huons Co Business Description

Traded in Other Exchanges
N/A
Address
902, Pangyo-ro Bundang-gu C, 253, Sampyeong-dong Bundang-gu, Gyeonggi-do, Seongnam, KOR, 13486
Huons Co Ltd is a Korean company. It is engaged in the manufacture and distribution of pharmaceutical products. The company produces pharmaceutical products including parenteral injections such as lidocaines, merit C injections; tablets such as phentermine, diet pills, and capsules such as Daisen and Fuxetine and other ethical and over-the-counter drugs. It also produces ampoules, vials, cartridges, and caps for use of medicals, foods, and cosmetics.

Huons Co Headlines

No Headlines